As advised via PHARMAC proposal of 22 October 2019 and the notification of PHARMAC decision of 5 December 2019 there is to be a change in the listing and future sole supply of bortezomib injections.

New listing from 1 March 2020

Bortezomib – Dr Reddy’s Inj 3.5 mg vial                                                                            Pharmacode TBA                  Schedule price $105.00

Bortezomib – Baxter Inj 1 mg for ECP                                                                                 Pharmacode TBA                  Schedule price $31.20

Incumbent brand Velcade

Velcade Inj 3.5 mg vial                                                                                                            Pharmacode 2275848       Schedule price $1892.50

Velcade – Baxter Inj 1 mg for ECP                                                                                        Pharmacode 2383667       Schedule price $594.77

HSS (Hospital Supply Status) & CSS (Community Supply Status) commences 1 August 2020.

PCT only – Specialist therefore only able to be dispensed and claimed by DHB Hospital Pharmacies.

Special Authority to be amended.

As of the date of this notification ProPharma / PWR cannot accept Velcade Inj for credit under any circumstances.

We would recommend you consider changing as soon as practical. This product is purchased on a PROCURE basis only.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author